IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.562
NA - Nord America 9.323
EU - Europa 7.252
SA - Sud America 3.948
AF - Africa 271
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 35.392
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.846
SG - Singapore 6.370
CN - Cina 3.776
BR - Brasile 3.325
HK - Hong Kong 2.261
SE - Svezia 1.875
IT - Italia 1.637
VN - Vietnam 1.024
RU - Federazione Russa 854
DE - Germania 746
GB - Regno Unito 399
FI - Finlandia 368
IN - India 297
RO - Romania 284
AR - Argentina 252
CA - Canada 224
AT - Austria 180
IE - Irlanda 178
MX - Messico 174
NL - Olanda 146
PL - Polonia 146
BD - Bangladesh 135
FR - Francia 132
JP - Giappone 126
ZA - Sudafrica 122
EC - Ecuador 114
ID - Indonesia 111
ES - Italia 103
TR - Turchia 90
IQ - Iraq 69
CO - Colombia 68
UA - Ucraina 59
PY - Paraguay 51
PK - Pakistan 45
LT - Lituania 44
MA - Marocco 39
VE - Venezuela 36
PE - Perù 35
CL - Cile 33
TN - Tunisia 30
UZ - Uzbekistan 30
NP - Nepal 29
EG - Egitto 25
UY - Uruguay 25
IR - Iran 24
BE - Belgio 20
IL - Israele 20
KE - Kenya 20
AE - Emirati Arabi Uniti 18
AU - Australia 17
JM - Giamaica 16
SA - Arabia Saudita 16
TW - Taiwan 16
CH - Svizzera 13
DZ - Algeria 12
DO - Repubblica Dominicana 11
KZ - Kazakistan 11
CR - Costa Rica 10
JO - Giordania 10
PT - Portogallo 10
HN - Honduras 9
RS - Serbia 9
AL - Albania 8
BH - Bahrain 8
GT - Guatemala 8
KR - Corea 8
LB - Libano 8
OM - Oman 8
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
EU - Europa 6
MY - Malesia 6
PH - Filippine 6
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
KG - Kirghizistan 5
KW - Kuwait 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
GE - Georgia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AO - Angola 3
BB - Barbados 3
GY - Guiana 3
HU - Ungheria 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
TG - Togo 3
TH - Thailandia 3
AM - Armenia 2
CI - Costa d'Avorio 2
DM - Dominica 2
ET - Etiopia 2
KH - Cambogia 2
Totale 35.349
Salva come PNG Salva come JPEG
Città #
Singapore 2.777
Hong Kong 2.247
Dallas 2.218
Ashburn 1.272
Shanghai 972
Hefei 881
Lawrence 592
Princeton 584
Beijing 514
Milan 478
New York 451
Ho Chi Minh City 372
Los Angeles 329
São Paulo 325
Moscow 263
Boardman 203
Hanoi 202
Nuremberg 200
Munich 198
Helsinki 185
Dublin 178
London 155
Rome 135
Warsaw 119
Rio de Janeiro 116
Tokyo 108
Turku 96
Washington 93
Denver 88
Pune 88
The Dalles 88
Montreal 87
Brooklyn 85
Poplar 84
Santa Clara 84
Lappeenranta 83
Orem 81
Stockholm 80
Vienna 80
Johannesburg 77
Belo Horizonte 73
Chennai 72
Atlanta 70
Phoenix 65
Columbus 64
Seattle 64
Chicago 60
Guangzhou 59
Brasília 58
Cesano Boscone 58
Frankfurt am Main 57
Mexico City 55
Ankara 50
Houston 50
San Francisco 46
Boston 44
Toronto 44
Amsterdam 42
Campinas 42
Biên Hòa 41
Curitiba 41
Porto Alegre 40
Da Nang 38
Guarulhos 37
Manchester 36
Quito 35
Guayaquil 34
Council Bluffs 33
Haiphong 33
Salvador 33
St Petersburg 33
Landshut 32
Shenzhen 31
Tianjin 31
Mumbai 30
Thái Bình 30
Hangzhou 29
Naples 29
Santo André 29
Baghdad 28
Dhaka 28
Ribeirão Preto 27
Tashkent 26
Turin 26
Falkenstein 25
Hải Dương 24
Assago 22
Brescia 22
Buenos Aires 22
Cape Town 22
Changsha 22
Goiânia 22
Jakarta 22
Querétaro 22
Contagem 21
Florence 21
Fortaleza 20
Brussels 19
Caxias do Sul 19
Montevideo 19
Totale 19.495
Salva come PNG Salva come JPEG
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 322
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes 215
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN) 154
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk 145
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3 125
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 120
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 117
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 116
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 113
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 113
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 112
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 109
A delphic consensus assessment: Imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management 105
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma 104
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial 103
A multimodality test to guide the management of patients with a pancreatic cyst 99
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 95
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 93
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 93
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 92
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 91
A preoperative score to predict early death after pancreatic cancer resection 90
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 90
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 88
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 88
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 88
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 87
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 86
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 85
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 84
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 84
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 84
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 82
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 82
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 81
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 81
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility 80
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) 80
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 80
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX 79
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 79
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 79
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 78
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 77
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 76
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 76
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 76
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 76
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 76
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts. 75
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma 75
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 75
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 75
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 74
ASO Author Reflections: The Impact of CT-assessed Liver Steatosis on Postoperative Complications after Pancreaticoduodenectomy for Cancer 74
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 74
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 74
ASO Visual Abstract: Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation Sequencing 73
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 72
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 72
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 72
Modelling centralization of pancreatic surgery in a nationwide analysis 72
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 71
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients 71
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 71
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 71
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 70
Recovery of health-related quality of life after laparoscopic versus open distal pancreatectomy 70
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 70
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 70
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 70
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 69
Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial 69
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 69
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 69
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 68
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 68
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 68
A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive techniqueand variability of perioperative pathways 68
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 67
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 67
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 67
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 67
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 67
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 67
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 66
Autologous Pancreatic Islet Cell Transplantation Following Pancreatectomy for Pancreas Diseases Other Than Chronic Pancreatitis: A 15-Y Study of the Milan Protocol 66
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 66
The impact of preoperative anemia on pancreatic resection outcomes 66
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 66
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival 66
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 66
Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies 66
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment 65
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 65
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer 65
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 65
Allo- and auto-percutaneous intra-portal pancreatic islet transplantation (PIPIT) for diabetes cure and prevention: the role of imaging and interventional radiology 65
A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors 65
Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy 65
Totale 8.452
Salva come PNG Salva come JPEG
Categoria #
all - tutte 290.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 290.281
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 57 28 2 3 0 0 0
2021/2022307 0 2 21 123 31 15 16 9 21 17 9 43
2022/20233.706 1.329 743 218 48 39 397 325 325 167 32 34 49
2023/20242.648 70 132 296 250 249 555 74 268 43 105 189 417
2024/202512.216 1.365 326 326 364 425 1.064 1.795 1.006 2.053 1.594 893 1.005
2025/202617.187 2.730 3.035 2.755 5.243 2.859 565 0 0 0 0 0 0
Totale 36.278